Badran, M., Abbas, S., Fujita, M., Osman, M. (2023). Derivatives contain dimethylaminopyridine as SIRT2 inhibitors: A mini review. Journal of advanced Biomedical and Pharmaceutical Sciences, 6(4), 166-173. doi: 10.21608/jabps.2023.219233.1191
Mostafa Badran; Samar H Abbas; Mikako Fujita; Mohamed Osman. "Derivatives contain dimethylaminopyridine as SIRT2 inhibitors: A mini review". Journal of advanced Biomedical and Pharmaceutical Sciences, 6, 4, 2023, 166-173. doi: 10.21608/jabps.2023.219233.1191
Badran, M., Abbas, S., Fujita, M., Osman, M. (2023). 'Derivatives contain dimethylaminopyridine as SIRT2 inhibitors: A mini review', Journal of advanced Biomedical and Pharmaceutical Sciences, 6(4), pp. 166-173. doi: 10.21608/jabps.2023.219233.1191
Badran, M., Abbas, S., Fujita, M., Osman, M. Derivatives contain dimethylaminopyridine as SIRT2 inhibitors: A mini review. Journal of advanced Biomedical and Pharmaceutical Sciences, 2023; 6(4): 166-173. doi: 10.21608/jabps.2023.219233.1191
Derivatives contain dimethylaminopyridine as SIRT2 inhibitors: A mini review
1Department of Medicinal Chemistry, Faculty of Pharmacy, South Valley University, Qena, 83523, Egypt
2Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, 61519-Minia, Egypt
3Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan
4Medicinal Chemistry Department, Faculty of Pharmacy, Minia University.
Abstract
The development of new compounds inhibiting SIRT2, a protein that regulates various biological processes, has attracted significant attention in recent years. This study reported dimethylaminopyridine (DMAP) synthesis and evaluation as a new scaffold for SIRT2 inhibition. DMAP derivatives were designed and synthesized using a combination of computational modeling and synthetic chemistry approaches. A high-throughput screening assay was used to evaluate the ability of compounds to inhibit SIRT2. The most potent compounds were identified and further characterized using cellular and enzymatic assays. This review suggests that DMAP could be a promising scaffold for developing novel SIRT2 inhibitors with potential anticancer activity.
View on SCiNiTO
Top